Clinical Trial

Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?

Study acronym: TARGET
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 25, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-05-16; most recent amendment 2025-03-24.
Status change: Not Yet Recruiting → Recruiting 2024-05-25
Trial Details
NCT Number NCT06420115
Lead Sponsor University Hospital Padova
Conditions Prostate Cancer Diagnosis
Enrollment 580 participants
Start Date 2024-06-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-25